OTC · CIK 0001684144
ZOMDF Zomedica Corp.
Insider trading from SEC Form 4. Last filing Nov 18, 2025. Close $0.08 on Oct 9, 2026, +38% from the 52-week low and -46% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
12
with a Form 4 at this company
Price and insider trades, last year
ZOMDFOct 9, 2026 · close 0.08
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Zomedica Corp., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | Russell Kevin Klass Sr Vice President, Sales buy | $15k 150,000 shares | +3% | +213% from low-36% from high | |
| 28Weak | Russell Kevin Klass Sr Vice President, Sales buy | $12k 120,000 shares | +2% | +223% from low-34% from high | |
| 23Weak | Russell Kevin Klass Sr Vice President, Sales buy | $475 5,000 shares | +0% | +220% from low-35% from high | |
| 28Weak | Russell Kevin Klass Sr Vice President, Sales buy | $20k 253,007 shares | +5% | +180% from low-43% from high | |
| 40Moderate | Russell Kevin Klass Sr Vice President, Sales buy | $42k 1,056,064 shares | +25% | +30% from low-74% from high | |
| 26Weak | Russell Kevin Klass Sr Vice President of Sales buy | $20k 500,000 shares | +16% | +23% from low-75% from high | |
| 31Weak | Russell Kevin Klass Sr Vice President of Sales buy | $20k 500,000 shares | +14% | +30% from low-74% from high | |
| 51Moderate | Anthony K Blair COO buy | $4,964 100,000 shares | +11% | +57% from low-68% from high | |
| 46Moderate | Karen DeHaan-Fullerton General Counsel/Corporate Secy buy | $5,006 104,300 shares | - | +57% from low-68% from high | |
| 41Moderate | Johnny D Powers director buy | $23k 500,000 shares | +17% | +57% from low-68% from high | |
| 45Moderate | Scott Jordan Chief Financial Officer buy | $19k 300,000 shares | - | - | |
| 50Moderate | Anthony K Blair COO buy | $30k 500,000 shares | +125% | - | |
| 55Moderate | Larry C Heaton II CEO buy | $30k 500,000 shares | +100% | - | |
| 43Moderate | Russell Kevin Klass Sr Vice President of Sales buy | $49k 699,980 shares | +28% | - | |
| 45Moderate | Anthony K Blair COO buy | $18k 150,000 shares | +60% | - | |
| 46Moderate | Larry C Heaton II CEO buy | $12k 100,000 shares | +25% | - | |
| 43Moderate | Russell Kevin Klass Vice President of Sales buy | $60k 500,000 shares | +50% | - | |
| 30Weak | Johnny D Powers director buy | $12k 100,000 shares | +4% | - |
Transactions
The last 49 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Christopher Ross Macleod director | AGrant or award Stock Appreciation Rightderivative | +1,823,107 | $0.00 | $0 | 1,823,107 | Nov 18, 2025 |
| Nov 17, 2025 | Robert Cohen director | AGrant or award Stock Appreciation Rightderivative | +1,823,107 | $0.00 | $0 | 1,823,107 | Nov 18, 2025 |
| Nov 17, 2025 | Rodney James Williams director | AGrant or award Stock Appreciation Rightderivative | +1,975,033 | $0.00 | $0 | 1,975,033 | Nov 18, 2025 |
| Nov 17, 2025 | Sean Whelan director | AGrant or award Stock Appreciation Rightderivative | +1,975,033 | $0.00 | $0 | 1,975,033 | Nov 18, 2025 |
| Nov 17, 2025 | Johnny D Powers director | AGrant or award Stock Appreciation Rightderivative | +1,823,107 | $0.00 | $0 | 1,823,107 | Nov 18, 2025 |
| Nov 17, 2025 | Pamela Nichols director | AGrant or award Stock Appreciation Rightderivative | +1,823,107 | $0.00 | $0 | 1,823,107 | Nov 18, 2025 |
| Nov 17, 2025 | Jeffrey M Rowe director | AGrant or award Stock Appreciation Rightderivative | +2,126,959 | $0.00 | $0 | 2,126,959 | Nov 18, 2025 |
| Nov 13, 2025 | Russell Kevin Klass Sr Vice President, Sales | POpen-market purchase Common Stock, without par value | +150,000 | $0.10 | $15k | 5,784,101 | Nov 14, 2025 |
| Nov 10, 2025 | Russell Kevin Klass Sr Vice President, Sales | POpen-market purchase Common Stock, without par value. | +120,000 | $0.10 | $12k | 5,634,101 | Nov 12, 2025 |
| Nov 7, 2025 | Russell Kevin Klass Sr Vice President, Sales | POpen-market purchase Common Stock, without par value | +5,000 | $0.10 | $475 | 5,514,101 | Nov 10, 2025 |
| Nov 6, 2025 | Russell Kevin Klass Sr Vice President, Sales | POpen-market purchase Common Stock, without par value | +253,007 | $0.08 | $20k | 5,509,101 | Nov 7, 2025 |
| Aug 11, 2025 | Russell Kevin Klass Sr Vice President, Sales | POpen-market purchase Common Stock, without par value | +60,723 | $0.04 | $2,429 | 4,260,753 | Aug 13, 2025 |
| Aug 12, 2025 | Russell Kevin Klass Sr Vice President, Sales | POpen-market purchase Common Stock, without par value | +250,000 | $0.04 | $10k | 4,510,753 | Aug 13, 2025 |
| Aug 12, 2025 | Russell Kevin Klass Sr Vice President, Sales | POpen-market purchase Common Stock, without par value | +745,341 | $0.04 | $30k | 5,256,094 | Aug 13, 2025 |
| Aug 11, 2025 | Russell Kevin Klass Sr Vice President of Sales | POpen-market purchase Common Stock, without par value | +250,000 | $0.04 | $9,500 | 3,950,030 | Aug 12, 2025 |
| Aug 8, 2025 | Russell Kevin Klass Sr Vice President of Sales | POpen-market purchase Common Stock, without par value | +500,000 | $0.04 | $20k | 3,700,030 | Aug 12, 2025 |
| Aug 11, 2025 | Russell Kevin Klass Sr Vice President of Sales | POpen-market purchase Common Stock, without par value | +250,000 | $0.04 | $10k | 4,200,030 | Aug 12, 2025 |
| Jun 12, 2025 | Anthony K Blair COO | AGrant or award Options to buy Common Stockderivative | +750,000 | $0.00 | $0 | 750,000 | Jun 16, 2025 |
| Jun 12, 2025 | Karen DeHaan-Fullerton General Counsel | AGrant or award Options to buy Common Stockderivative | +500,000 | $0.00 | $0 | 500,000 | Jun 16, 2025 |
| Jun 12, 2025 | Larry C Heaton II CEO | AGrant or award Options to buy Common Stockderivative | +4,000,000 | $0.00 | $0 | 4,000,000 | Jun 16, 2025 |
| Jun 12, 2025 | Russell Kevin Klass Sr Vice President of Sales | AGrant or award Options to buy Common Stockderivative | +500,000 | $0.00 | $0 | 500,000 | Jun 16, 2025 |
| May 21, 2025 | Anthony K Blair COO | POpen-market purchase Common Stock, without par value | +36,250 | $0.05 | $1,776 | 936,250 | May 21, 2025 |
| May 21, 2025 | Anthony K Blair COO | POpen-market purchase Common Stock, without par value | +63,750 | $0.05 | $3,188 | 1,000,000 | May 21, 2025 |
| May 19, 2025 | Johnny D Powers director | POpen-market purchase Common Stock, without par value | +500,000 | $0.05 | $23k | 3,425,000 | May 20, 2025 |
| May 19, 2025 | Karen DeHaan-Fullerton General Counsel/Corporate Secy | POpen-market purchase Common Stock, without par value | +104,300 | $0.05 | $5,006 | 104,300 | May 20, 2025 |
| Mar 17, 2025 | Scott Jordan Chief Financial Officer | POpen-market purchase Common Stock, without par value | +300,000 | $0.06 | $19k | 300,000 | Mar 19, 2025 |
| Mar 17, 2025 | Anthony K Blair COO | POpen-market purchase Common Stock, without par value | +500,000 | $0.06 | $30k | 900,000 | Mar 18, 2025 |
| Mar 17, 2025 | Larry C Heaton II CEO | POpen-market purchase Common Stock, without par value | +10,000 | $0.05 | $540 | 510,000 | Mar 18, 2025 |
| Mar 17, 2025 | Russell Kevin Klass Sr Vice President of Sales | POpen-market purchase Common Stock, without $0.070 par value | +699,980 | $0.07 | $49k | 3,200,030 | Mar 18, 2025 |
| Mar 17, 2025 | Larry C Heaton II CEO | POpen-market purchase Common Stock, without par value | +118,855 | $0.06 | $6,894 | 628,855 | Mar 18, 2025 |
| Mar 17, 2025 | Larry C Heaton II CEO | POpen-market purchase Common Stock, without par value | +191,817 | $0.06 | $12k | 820,672 | Mar 18, 2025 |
| Mar 17, 2025 | Larry C Heaton II CEO | POpen-market purchase Common Stock, without par value | +179,328 | $0.06 | $11k | 1,000,000 | Mar 18, 2025 |
| Feb 21, 2025 | Russell Kevin Klass Sr Vice President of Sales | AGrant or award Option to buy common stockderivative | +200,000 | $0.00 | $0 | 200,000 | Feb 24, 2025 |
| Jan 1, 2025 | Scott Jordan Chief Financial Officer | AGrant or award Options to buy common stockderivative | +5,000,000 | $0.00 | $0 | 5,000,000 | Jan 3, 2025 |
| Nov 10, 2024 | Rodney James Williams director | AGrant or award Stock Appreciation Rightsderivative | +1,975,033 | $0.00 | $0 | 1,975,033 | Nov 26, 2024 |
| Nov 8, 2024 | Anthony K Blair COO | POpen-market purchase Common Stock, without par value | +150,000 | $0.12 | $18k | 400,000 | Nov 13, 2024 |
| Nov 11, 2024 | Sean Whelan director | AGrant or award Stoock Appreciation Rightsderivative | +1,975,033 | $0.00 | $0 | 1,975,033 | Nov 13, 2024 |
| Nov 11, 2024 | Jeffrey M Rowe director | AGrant or award Stock Appreciation Rightsderivative | +2,126,959 | $0.00 | $0 | 2,126,959 | Nov 13, 2024 |
| Nov 11, 2024 | Johnny D Powers director | AGrant or award Stock Appreciation Rightsderivative | +1,975,033 | $0.00 | $0 | 1,975,033 | Nov 13, 2024 |
| Nov 11, 2024 | Johnny D Powers director | AGrant or award Stock Appreciation Rightsderivative | +1,823,107 | $0.00 | $0 | 1,823,107 | Nov 13, 2024 |
| Nov 11, 2024 | Pamela Nichols director | AGrant or award Stock Appreciation Rightsderivative | +1,975,033 | $0.00 | $0 | 1,975,033 | Nov 13, 2024 |
| Nov 11, 2024 | Christopher Ross Macleod director | AGrant or award Stock Appreciation Rightsderivative | +1,823,107 | $0.00 | $0 | 1,823,107 | Nov 13, 2024 |
| Nov 11, 2024 | Karen DeHaan-Fullerton General Counsel/Corporate Secy | AGrant or award Options to Buy Common Stockderivative | +500,000 | $0.00 | $0 | 500,000 | Nov 13, 2024 |
| Nov 11, 2024 | Robert Cohen director | AGrant or award Stock Appreciation Rightsderivative | +1,823,107 | $0.00 | $0 | 1,823,107 | Nov 13, 2024 |
| Nov 11, 2024 | Anthony K Blair COO | AGrant or award Options to Buy Common Stockderivative | +400,000 | $0.00 | $0 | 400,000 | Nov 13, 2024 |
| Nov 11, 2024 | Johnny D Powers director | POpen-market purchase Common Stock, without par value | +100,000 | $0.12 | $12k | 2,425,000 | Nov 12, 2024 |
| Nov 11, 2024 | Russell Kevin Klass Vice President of Sales | POpen-market purchase Common Stock, without par value | +210,200 | $0.12 | $25k | 1,210,250 | Nov 12, 2024 |
| Nov 11, 2024 | Larry C Heaton II CEO | POpen-market purchase Common Stock, without par value | +100,000 | $0.12 | $12k | 500,000 | Nov 12, 2024 |
| Nov 11, 2024 | Russell Kevin Klass Vice President of Sales | POpen-market purchase Common Stock, without par value | +289,800 | $0.12 | $35k | 1,500,050 | Nov 12, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Anthony K BlairCOO
- Robert Cohendirector
- Karen DeHaan-FullertonGeneral Counsel
- Larry C Heaton IICEO
- Scott JordanChief Financial Officer
- Russell Kevin KlassSr Vice President, Sales
- Christopher Ross Macleoddirector
- Pamela Nicholsdirector
- Johnny D Powersdirector
- Jeffrey M Rowedirector
- Sean Whelandirector
- Rodney James Williamsdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.